Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Jan 30, 2013, we downgraded Molina Healthcare Inc. ( MOH - Analyst Report ) to Neutral from Outperform based on its rising medical costs and the negative impact of the healthcare reforms.
Why the Downgrade?
Molina is witnessing rising medical care costs, which are compressing margins. Further, the establishment of the medical loss ratio mandate of the healthcare reform is increasing the costs of healthcare companies.
Further changes, which will be implemented from 2014, such as the ban on annual and lifetime coverage caps, annual fees on health insurance companies and excise tax on high premium insurance policies, will likely increase the expenses of healthcare companies such as Coventry Health Care Inc. ( ) and Health Net, Inc. ( HNT - Analyst Report ) .
Molina also lost a couple of important Medicaid contracts in 2012, which are expected to reduce membership base, thereby negatively impacting revenues. The loss of the Missouri Medicaid contract reduced this managed care company’s membership by about 79,000 members. Investment income, another prime component of Molina’s revenue, has been declining since 2007, primarily due to lower interest rates.
Moreover, the Zacks Consensus Estimate for Molina’s fourth-quarter 2012 earnings declined 4.6% to 21 cents during the last 30 days based on 2 downward estimate revisions. Additionally, over the last 30 days, the Zacks Consensus Estimate for 2012 of a loss of 12 cents widened 8.3% to 13 cents. Both the quarterly and annual results will likely decline 60% and 108% year-over-year, respectively.
These downward estimate revisions also had an impact on Molina’s Zacks Rank, which was downgraded to Zacks Rank #3 (Hold) from Zacks Rank #2 (Buy).
Molina is scheduled to report its fourth quarter and full year 2012 results on Feb 7.
Other Stocks to Consider
While we remain cautious on Molina, another health maintenance organization American Caresource Holdings, Inc. ( ANCI - Snapshot Report ) , carrying a Zacks Rank #2 (Buy), is worth considering.
Read the full reports :
Analyst Report on MOH
Analyst Report on HNT
Snapshot Report on ANCI